NCT01154920 2025-12-17Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting128 enrolled
NCT04675333 2025-08-03Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)ALX Oncology Inc.Phase 2 Active not recruiting172 enrolled
NCT06110195 2025-06-08Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck CancerUniversity of ChicagoPhase 1 Active not recruiting42 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled